The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy
- 1 November 2001
- journal article
- Published by Elsevier in The American Journal of Medicine
- Vol. 111 (7), 528-534
- https://doi.org/10.1016/s0002-9343(01)00928-7
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Introduction to Antifungal DrugsClinical Infectious Diseases, 2000
- Clinical Significance of Nephrotoxicity in Patients Treated with Amphotericin B for Suspected or Proven AspergillosisClinical Infectious Diseases, 1999
- Editorial Response: Approaches to Therapy for Invasive Mycoses‐‐The Role of Amphotericin BClinical Infectious Diseases, 1998
- Predictability of creatinine clearance estimates in critically ill patientsCritical Care Medicine, 1993
- Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic MonitoringThe Journal of Infectious Diseases, 1993
- The HELP system and its application to infection controlJournal of Hospital Infection, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Amphotericin B NephrotoxicityDrug Safety, 1990
- ACUTE RENAL TOXICITY WITH COMBINED USE OF AMPHOTERICIN B AND CYCLOSPORINE AFTER MARROW TRANSPLANTATIONTransplantation, 1983
- Nephrotoxicity Associated with Combined Gentamicin – Amphotericin B TherapyNephron, 1977